# history.md — Opportunity Log

Append-only record of every opportunity flagged by the Speculation Research System. Entries are
never edited or deleted; corrections are appended as new dated lines. Retired entries stay here
permanently so that the system can be judged on what it said at the time.

**Educational guidance, not personalised financial advice.** Named companies are examples of where a
narrative is being expressed, not endorsements. No live market data is used.

Format: `Date | Opportunity | Market | Narrative | Sentiment | Hype stage | Tier | Score | Source`

---

## 2026-07-28 — Run #1 (v1.0 initial scan)

Scope: ASX small/microcaps, US small/microcaps, alternative assets. 12 opportunities logged,
8 narratives registered. No Tier 4 entries — deliberate.

| # | Opportunity | Market | Narrative | Sentiment | Stage | Tier | Score | Source |
|---|---|---|---|---|---|---|---|---|
| 1 | Rare earths & critical minerals ex-China (Lynas, Iluka, Arafura, Brazilian Rare Earths, Lindian) | ASX | Western supply chains building non-Chinese rare-earth capacity after export restrictions; EV, defence and magnet demand pull | Excited | Acceleration | 2 | 78 | [INN](https://investingnews.com/best-rare-earth-stocks-asx), [Livewire](https://www.livewiremarkets.com/wires/7-magnificent-miners-2026-s-top-picks-in-copper-iron-ore-lithium-rare-earths-gold-silver-and-uranium) |
| 2 | Critical-minerals capital discrimination (funded vs unfunded explorers) | ASX | Widening gap between explorers who can show funding, technical progress and a path to cash flow, and those who cannot | Cautious | Emergent | 2 | 76 | [Kalkine](https://kalkine.com.au/news/mining/top-12-asx-critical-minerals-stocks-for-august-26-could-lithium-copper-rare-earths-uranium-and-gold-ignite-the-next-resources-rally) |
| 3 | ASX gold-developer consolidation (Vault / Genesis / Regis) | ASX | Sustained gold price pushing producers to buy ounces rather than drill for them; Genesis ~$5bn offer for Vault above a competing Regis bid | Excited | Acceleration | 1 | 74 | [HotCopper Wk28](https://hotcopper.com.au/news/market-summary/155159/hotcopper-highlights-week-28-tech-stock-relief-asxs-largest-ipo-of-2026-more/) |
| 4 | Prediction markets as an asset class (Kalshi, Polymarket) | Alt | Monthly volume from <$5bn (Sep 2025) to ~$21–24bn (Apr 2026); Kalshi overtook Polymarket, ~83% of CFTC-approved notional through the World Cup final; ~40% institutional | Excited | Acceleration | 2 | 72 | [TRM Labs](https://www.trmlabs.com/resources/blog/how-prediction-markets-scaled-to-usd-21b-in-monthly-volume-in-2026), [Pew](https://www.pewresearch.org/short-reads/2026/05/27/trading-volume-on-prediction-markets-has-soared-in-recent-months/) |
| 5 | Uranium & nuclear fuel cycle (Minerals 260 project suite and peers) | ASX | Datacentre power demand plus nuclear baseload policy shift reviving a long-dormant narrative; decade-long supply response | Excited | Acceleration | 3 | 68 | [IBTimes AU](https://www.ibtimes.com.au/minerals-260-ltd-small-cap-success-asx-1871046) |
| 6 | ASX antimony, gold & critical-mineral explorers (NPM, AKN, AT4, CHW) | ASX | Antimony's strategic-mineral status plus Chinese export controls pulling tiny explorers into a large theme | Cautious | Emergent | 3 | 64 | [Proactive](https://www.proactiveinvestors.com/companies/news/1093490/small-cap-watch-small-cap-explorers-advance-gold-rare-earths-and-antimony-projects-1093490.html) |
| 7 | Space & satellite speculation (Rocket Lab, AST SpaceMobile, SpaceX secondaries) | US | Rocket Lab #2 and AST SpaceMobile #3 in WSB 2026 picks; real launch cadence, valuation on the 2030s | Excited | Acceleration | 2 | 61 | [Finbold](https://finbold.com/wallstreetbets-top-10-stock-picks-for-2026/) |
| 8 | Semiconductor options mania (ASML, MU, AI-infrastructure complex) | US | Record ~$6.8bn/day retail options premium in June 2026, +17% on May's record and >2x historical average; ~$1.9bn/day in semis alone (6x average); ASML WSB mentions +2,350% in 24h to 28 Jul | Euphoric | Saturation | 1 | 58 | [Citadel Securities](https://www.citadelsecurities.com/news-and-insights/global-market-intelligence/1h-2026-market-structure-flows/), [AltIndex](https://altindex.com/wallstreetbets) |
| 9 | ASX IPO-flip trade (FDC Consolidated Holdings) | ASX | Largest ASX IPO of 2026; debate over whether debut-day gains hold, answerable mechanically via escrow and lock-up expiry | Neutral | Acceleration | 2 | 57 | [HotCopper Wk28](https://hotcopper.com.au/news/market-summary/155159/hotcopper-highlights-week-28-tech-stock-relief-asxs-largest-ipo-of-2026-more/) |
| 10 | Quantum computing pure-plays (IonQ, Rigetti, D-Wave) | US | Pure-plays +50%+ since late March; benchmark quantum index ~+69% to end-May vs S&P 500 ~+11%; minimal revenue, no profits; May 2026 US Commerce $2bn CHIPS-Act allocation the policy catalyst | Euphoric | Saturation | 2 | 55 | [Motley Fool](https://www.fool.com/investing/stock-market/market-sectors/information-technology/ai-stocks/quantum-computing-stocks/), [US News](https://money.usnews.com/investing/articles/best-quantum-computing-stocks-to-buy) |
| 11 | ASX lithium recovery trade (Liontown and the developer complex) | ASX | Dominated HotCopper Week 28 discussion; recovery narrative genuine but has been "about to turn" for several cycles | Neutral | Latent → Emergent | 2 | 54 | [Discovery Alert](https://discoveryalert.com.au/hotcopper-highlights-week-28-asx-stocks-market-sentiment-2026/) |
| 12 | Graded collectibles & Pokémon (TCG, cards, watches) | Alt | Market $320bn–$602bn depending on definition; $16.5m Pokémon card sale (Feb 2026) crystallised the asset-class story; Japan moving to regulate; overproduction diluting lower tiers | Euphoric | Saturation | 3 | 42 | [CNBC](https://www.cnbc.com/2026/02/25/pokmon-card-winner-scaramucci-says-collectibles-are-asset-class.html), [HokaNews](https://www.hokanews.com/2026/07/japan-moves-to-regulate-exploding.html) |
| 13 | BrainChip / neuromorphic commercialisation (ASX:BRN) | ASX | Long-running commercialisation debate; technology narrative genuine, revenue conversion chronically late. Live case study in "perpetual near-term milestones" | Excited | Decay ↔ Recycle | 3 | 38 | [Discovery Alert](https://discoveryalert.com.au/hotcopper-highlights-week-28-asx-stocks-market-sentiment-2026/) |

### Narratives registered this run

| Narrative | Stage | Direction | Kill condition |
|---|---|---|---|
| Non-China critical minerals | Acceleration | ↑ Building | Policy reversal; Chinese supply normalising; a funded competitor commissioning early |
| AI infrastructure buildout | Saturation | → Flat, crowded | A single major capex cut; good earnings met with flat prices |
| Quantum as "the next AI" | Saturation | ↑ Overheated | A funding tranche landing with no price reaction; a missed technical milestone |
| Nuclear / uranium revival | Acceleration | ↑ Building | Project delays; an incident anywhere in the world |
| Prediction markets mainstream | Acceleration | ↑ Fast | An adverse CFTC or state ruling; a resolution scandal |
| Space commercialisation | Acceleration | → Steady | A launch failure; a down-round |
| Collectibles as an asset class | Saturation | ↓ Rolling over | Regulation (already arriving in Japan); oversupply in lower tiers |
| Lithium price recovery | Latent → Emergent | → Waiting | Another quarter of oversupply; a second failed "turn" |

### Idea of the Day — #2, Critical-minerals capital discrimination (score 76)

**Selected over the higher-scoring rare earths entry (78)** because rare earths is a crowded Acceleration-stage
narrative and this is an Emergent one. Two points of score is a rounding error; one stage of hype cycle is not.
The gold M&A situation (74) was the runner-up but its catalyst resolves to a board's decision, which cannot be
researched into an edge.

**Thesis.** Capital in ASX critical minerals has stopped rewarding the theme and started rewarding the balance
sheet. The tradeable event is the widening gap between funded and unfunded explorers — and that gap gets
published, on a legal deadline, in the Aug–Sep quarterly cashflow reports (Appendix 5B).

**Why the catalyst scores 20/20.** Appendix 5B lodgements are dated, mandatory, public and standardised. Cash
divided by burn gives quarters of runway, which predicts who must raise at a discount. Almost every other catalyst
on this watchlist is a guess about geology, policy or someone else's decision. This one is arithmetic on a document
with a filing deadline.

**What must be true:** (1) the discrimination continues rather than reverses; (2) runway is genuinely predictive of
the next raise; (3) the funded names are not already priced for it.

**Strongest case against.** It may not be an edge at all — "quality over junk within a hot sector" is a known
factor that institutions run systematically with better data. Dispersion trades are also slow and unsatisfying:
you can be entirely right about which explorer runs out of money and make nothing, because the market punishes the
raise for a week and forgets. And the whole premise depends on the commodity narrative holding up — if critical
minerals roll over, funded and unfunded fall together.

**Kill conditions (observable):** unfunded explorers outperforming funded peers over a month; Aug–Sep cashflow
reports landing with no differentiated price reaction; the critical-minerals narrative hitting Saturation (good
news met with a flat close); a policy reversal on export controls.

**Not picked, and why:** quantum pure-plays (55) — euphoric, saturated, no revenue, interesting is not early.
Semiconductor options flow (58) — record premium is a fact about positioning, not value. Collectibles (42) —
carried as a worked example of a saturation-stage narrative.

**Framing note.** This is a research subject, not a buy call, and is deliberately not one. Recorded here so the
selection logic can be judged against what actually happens.

### Run notes

- **Crowding observation.** Eight of twelve themes read Excited or Euphoric. Recorded as the single most
  important line in this run: a watchlist concentrated in the hot half of the sentiment map is one position
  wearing twelve costumes.
- **Deliberate scoring outcome.** The two highest-attention items (semiconductor options flow, quantum
  pure-plays) score in the 50s because the hype-cycle and sentiment dimensions penalise crowding. If a future
  run produces high scores on the most-discussed items, that is a signal the scoring has drifted.
- **No Tier 4 entries.** Nothing meme-level met the bar for inclusion this run. Logged as a fact, not an
  omission.
- **Retirement triggers set.** Entries retire when the catalyst passes, the narrative reaches Decay, the score
  falls 20+ points from entry, or 45 days pass with no new information.
- **Weakest links in this run.** Uranium (#5) and BrainChip (#13) both rely on undated catalysts — flagged for
  score review rather than carried forward on attention alone. The collectibles entry (#12) is included
  specifically as a live example of a saturation-stage narrative, not as a research subject with runway.

---

## 2026-07-29 — Run #2

Scope: ASX small/microcaps, US small/microcaps, alternative assets, cross-cutting policy. 16 source queries.
3 new opportunities, 6 materially changed, 3 retired, 4 carried unchanged. 13 active, 10 narratives registered.
Two new narratives registered; one of them deliberately not expressed as a watchlist entry.

| # | Opportunity | Market | Narrative | Sentiment | Stage | Tier | Score | Source |
|---|---|---|---|---|---|---|---|---|
| 1 | **Medicare reimbursement calendar** (US small-cap medtech with concentrated billing-code exposure) — **NEW** | US | Reimbursement as a catalyst class: for some small-cap device and diagnostics companies the regulator's rate table is closer to the fundamentals than the investor deck. CMS-1848-P issued 14 Jul; comments close 14 Sep; final rule in autumn; rates effective 1 Jan 2027. Conversion factor proposed to fall $33.5675→$33.1693 (APM) and $33.4009→$32.8409 (non-APM). Precedent: Sanuwave fell 5.25% when CMS left CPT 97610 unchanged in the CY2026 final rule | Neutral | Latent → Emergent | 2 | 83 | [CMS](https://www.cms.gov/newsroom/fact-sheets/calendar-year-cy-2027-medicare-physician-fee-schedule-proposed-rule), [Holland & Knight](https://www.hklaw.com/en/insights/publications/2026/07/cms-issues-cy-2027-medicare-physician-fee-schedule-proposed-rule), [StockTitan](https://www.stocktitan.net/news/SNWV/cms-publishes-final-rule-for-calendar-year-2026-physician-fee-bahl0popqdef.html) |
| 2 | **SpaceX listed-float mechanics (NASDAQ:SPCX)** — **NEW**, supersedes the generic space entry | US | The tradeable content of the space narrative has moved from launch cadence to share supply. ~911.5m shares begin unlocking on a staggered schedule (~7% tranches at days 70/90/105/120/135) rather than one 180-day cliff, plus a conditional 10% release if the stock holds 30% above the $135 IPO price for five of ten sessions. Musk's ~6.4bn shares locked to 12 Jun 2027. Q2 results 4 Aug; first major tranche 6 Aug | Excited | Acceleration | 1 | 82 | [Investing.com](https://www.investing.com/news/stock-market-news/spacex-ipo-lockup-expiry-123b-in-shares-set-to-unlock-in-early-august-2026-93CH-4796311), [Crypto Briefing](https://cryptobriefing.com/spacex-ipo-lockup-expiration-august/) |
| 3 | Rare earths and the 10 November cliff (was "Rare earths & critical minerals ex-China", 78) — **CHANGED** | ASX | Reframed. China's suspension of the October 2025 controls expires 10 Nov 2026; the April 2025 licensing regime was never suspended. Meanwhile magnet exports to the US hit a six-month high and H1 export value rose 61.1% YoY on 6.4% lower volume. The ex-China buildout thesis now runs into a dated, binary sovereign decision | Excited (cooling) | Acceleration ↓ | 2 | 77 | [China Briefing](https://www.china-briefing.com/news/chinas-rare-earth-export-controls-impacts-on-businesses/), [Morgan Lewis](https://www.morganlewis.com/pubs/2026/07/recent-china-export-control-actions-signal-active-enforcement-for-rare-earths-and-strategic-minerals), [Nikkei Asia](https://asia.nikkei.com/economy/trade-war/trump-tariffs/china-s-rare-earth-magnet-exports-to-us-hit-6-month-high) |
| 4 | Critical-minerals capital discrimination (was 76) — **CHANGED −4** | ASX | Correction to the Run #1 entry: June-quarter Appendix 5B lodgements are due **31 July**, not Aug–Sep, and item 8.3 of the form already requires the company to state its own estimated quarters of funding available. The runway arithmetic is disclosed, not derived — which weakens the under-read-information premise that justified the original score | Cautious | Emergent | 2 | 72 | [ASX Appendix 5B](https://www.asx.com.au/content/dam/asx/rules-guidance-notes-waivers/asx-listing-rules/appendices/Appendix_05B.pdf), [ASX GN23](https://www.asx.com.au/content/dam/asx/rules-guidance-notes-waivers/asx-listing-rules/guidance-notes/gn23-quarterly-reporting.pdf) |
| 5 | Prediction markets as an asset class (was 72) — **CHANGED −1** | Alt | Kalshi monthly volume ~$33bn in June; the two venues past $150bn lifetime. The stage marker to watch is the ETF wrapper: three issuers filed for up to 24 event-contract ETFs, the SEC delayed all of them in early May and opened a comment period on 20 May over valuation, settlement and disclosure. Minnesota's ban preliminarily enjoined 27 Jul; a New York court declined to block enforcement. Narrative advanced, hype position worsened | Excited | Acceleration → Saturation gate | 2 | 71 | [CoinDesk](https://www.coindesk.com/policy/2026/07/27/kalshi-polymarket-win-pause-against-minnesota-s-prediction-market-ban), [National Law Journal](https://www.law.com/nationallawjournal/2026/06/30/sec-eyes-new-etf-rules-amid-rise-of-prediction-market-funds/), [RotoWire](https://www.rotowire.com/prediction-markets/legal-timeline) |
| 6 | Uranium & nuclear fuel cycle (was 68, Tier 3) — **CHANGED −2, TIER 3 → TIER 2** | ASX | The undated catalyst arrived and was consumed. Australia–India uranium framework signed 9 Jul during Modi's Melbourne visit; ASX uranium names rose 7–14%. It is a permission structure, not a supply chain — volumes, timelines and pricing undisclosed, commercial offtakes still to be negotiated. **Tier change is structural, not performance-based:** the expression migrated from microcap explorers to liquid developers (Boss, Deep Yellow, Bannerman, Paladin) with better disclosure and order books | Excited | Acceleration ↑ | 2 | 66 | [Al Jazeera](https://www.aljazeera.com/news/2026/7/9/australia-india-strike-deal-on-uranium-exports-during-pm-modis-visit), [Proactive](https://www.proactiveinvestors.com.au/companies/news/1095234/australia-india-uranium-deal-opens-major-new-market-for-local-producers-1095234.html), [Stockhead](https://stockhead.com.au/news/closing-bell-uranium-stocks-fire-up-as-australia-and-india-ink-supply-agreement/) |
| 7 | ASX antimony & critical-mineral explorers (was 64) — **CHANGED +1** | ASX | Krakatoa Resources reported multiple zones of visual antimony in diamond drilling at Zopkhito, Georgia — including 2.86m with visually estimated content around 50% — raised $1.6m by placement, and is running the 2026 resource campaign roughly two months ahead of last year. Visual estimates are not assays; the assay results are the real catalyst | Cautious | Emergent | 3 | 65 | [Proactive weekly wrap](https://www.proactiveinvestors.com/companies/news/1095977/the-small-cap-weekly-wrap-campaign-launches-target-expansions-capital-raises-and-more-1095977.html) |
| 8 | **ASX copper discovery cycle** (Solstice Minerals ASX:SLS, Nanadie Well WA) — **NEW** | ASX | A discovery-drought narrative breaking. Combined RC + diamond intercept of 629.1m at 0.50% Cu and 0.17g/t Au from surface, including 30.7m at 1.41% Cu from 461.5m and 15m at 2.12% Cu from 473m, extending mineralisation >300m below an inferred resource of 40.4Mt at 0.4% Cu. Program expanded 1,300m to 6,300m; 11 diamond tails pending hole-by-hole through H2 2026 | Excited | Emergent | 3 | 61 | [Livewire](https://www.livewiremarkets.com/wires/solstice-shares-head-for-the-sun-as-bumper-copper-gold-hits-break-discovery-drought), [Small Caps](https://smallcaps.com.au/article/solstice-minerals-extends-nanadie-copper-gold-system-at-depth), [Australian Mining](https://www.australianmining.com.au/nanadie-delivers-mammoth-copper-gold-intercept-for-solstice) |
| 9 | ASX IPO-flip trade (FDC Consolidated Holdings) — carried, no new information | ASX | Unchanged from Run #1. Flagged against the 45-day staleness rule | Neutral | Acceleration | 2 | 57 | [HotCopper Wk28](https://hotcopper.com.au/news/market-summary/155159/hotcopper-highlights-week-28-tech-stock-relief-asxs-largest-ipo-of-2026-more/) |
| 10 | ASX lithium recovery trade (Liontown and the developer complex) — carried, no new information | ASX | Unchanged from Run #1. Flagged against the 45-day staleness rule | Neutral | Latent → Emergent | 2 | 54 | [Discovery Alert](https://discoveryalert.com.au/hotcopper-highlights-week-28-asx-stocks-market-sentiment-2026/) |
| 11 | Semiconductor & AI-infrastructure complex (was 58) — **CHANGED −10** | US | The Run #1 crowding warning was tested in 24 hours. WSB mentions of ASML spiked 2,350% in the day to 28 Jul; on 28 Jul a report that a Chinese state-backed producer had begun mass-producing immersion DUV lithography tools (~5 units in 2026 to SMIC, Hua Hong, CXMT; ~20 in 2027) sent ASML down ~5.7%, dragged AMAT/LRCX/KLA lower, and put a Bloomberg gauge of Asian semis down 7.5% — its worst session since April 2025. Analysts note key components remain Japanese-sourced and a handful of tools is not high-volume manufacturing | Euphoric, turning | Saturation → Decay | 1 | 48 | [Tom's Hardware](https://www.tomshardware.com/tech-industry/semiconductors/china-begins-mass-production-of-domestic-immersion-duv-lithography-machines), [CNBC](https://www.cnbc.com/2026/07/28/china-chipmaking-duv-tool-asml-explained.html), [TrendForce](https://www.trendforce.com/news/2026/07/28/news-china-reportedly-starts-mass-producing-immersion-duv-tools-smic-hua-hong-cxmt-deliveries-expected-this-year/) |
| 12 | Quantum computing pure-plays (was 55) — **CHANGED −9** | US | The hype cycle turned. IonQ −35.7% over 30 days, Rigetti −29%, D-Wave −27.8%; Rigetti −42.1% and QUBT −36.6% from June highs as capital rotated out of high-beta technology. Sell-side price targets unchanged and still implying triple-digit upside — a statement about positioning, not about the businesses, whose revenue and profits did not change | Euphoric, turning | Saturation ↓ | 2 | 46 | [Yahoo Finance](https://finance.yahoo.com/markets/stocks/articles/ionq-rigetti-d-wave-quantum-183030435.html), [Motley Fool](https://www.fool.com/investing/stock-market/market-sectors/information-technology/ai-stocks/quantum-computing-stocks/) |
| 13 | BrainChip / neuromorphic commercialisation (ASX:BRN) — carried, no new information | ASX | Unchanged from Run #1. Flagged against the 45-day staleness rule | Excited | Decay ↔ Recycle | 3 | 38 | [Discovery Alert](https://discoveryalert.com.au/hotcopper-highlights-week-28-asx-stocks-market-sentiment-2026/) |

### Retired this run

| Entry | Entry score | Rule triggered | Detail |
|---|---:|---|---|
| ASX gold-developer consolidation (Vault / Genesis / Regis) | 74 | **Catalyst passed** | Regis confirmed on 13 July it would not match the Genesis proposal and accepted termination of its agreement with Vault; the Vault board unanimously determined Genesis superior at a 14.5% premium (0.7629 Genesis shares + A47.5¢ cash, ~A$5.274/share, ~A$5.6bn). The competitive tension is gone; what remains is a scheme process. [Mining.com.au](https://mining.com.au/regis-drops-vault-minerals-bid-as-genesis-takes-lead/), [Proactive](https://www.proactiveinvestors.com/companies/news/1095308/genesis-minerals-clears-path-for-5-6-billion-vault-takeover-1095308.html) |
| Graded collectibles & Pokémon | 42 | **Narrative reached Decay** | In the tradeable segment. Modern cards down 20–45% and sealed product sliding while vintage continues setting records — a bifurcation, not a broad correction. The speculatively accessible half is the falling half. [Card Collector](https://cardcollector.co.uk/pokemon-card-prices-are-finally-slowing-down), [Pokémon Price Tracker](https://www.pokemonpricetracker.com/blog/posts/pokemon-card-market-crash-2026-signs-how-to-prepare) |
| Space & satellite speculation (generic) | 61 | **Superseded** | The tradeable content is now a dated supply event and is logged separately as entry #2. Carrying both would double-count one idea. |

### Narrative register state — 29 July 2026

| Narrative | Stage | Direction (vs Run #1) | First logged | Kill condition status |
|---|---|---|---|---|
| Non-China critical minerals | Acceleration | ↓ Cooling into a dated cliff (was ↑ Building) | 28 Jul 2026 | "Chinese supply normalising" partly firing — magnet exports to the US at a six-month high |
| AI infrastructure buildout | Saturation → Decay | ↓ Cracking (was → Flat, crowded) | 28 Jul 2026 | **Firing.** Chinese immersion DUV entering production; AI-debt concerns; −7.5% one-day in Asian semis |
| Quantum as "the next AI" | Saturation | ↓ Unwinding (was ↑ Overheated) | 28 Jul 2026 | **Partly firing.** 27–42% drawdowns with unchanged targets and unchanged fundamentals |
| Nuclear / uranium revival | Acceleration | ↑ Building | 28 Jul 2026 | Not firing. Framework signed; offtakes pending |
| Prediction markets go mainstream | Acceleration → Saturation gate | ↑ Fast | 28 Jul 2026 | Mixed. Minnesota win; New York adverse; SEC holding the ETF door shut |
| Space commercialisation | Acceleration | → Steady, now expressed as float mechanics | 28 Jul 2026 | Not firing. August lock-up absorption is the test |
| Collectibles as an asset class | Decay (modern) / Saturation (vintage) | ↓ Bifurcated | 28 Jul 2026 | **Firing.** Oversupply in lower tiers; Japanese regulation arriving |
| Lithium price recovery | Latent → Emergent | → Waiting (no new information) | 28 Jul 2026 | Not assessed this run |
| **Reimbursement as a catalyst class** — NEW | Latent → Emergent | ↑ Registered this run | 29 Jul 2026 | Kill: sell-side code-level notes appearing within days of a proposed rule; the rulemaking calendar slipping |
| **Defence procurement reform (Australia)** — NEW | Latent | → Registered, not expressible | 29 Jul 2026 | Kill: the reform being exactly what it says — cost discipline, not new spending. **No sourced ASX small-cap expression, so deliberately not placed on the watchlist** |

### Idea of the Day — #1, The Medicare reimbursement calendar as a catalyst class (score 83)

**Selection logic.** It is today's highest scorer, which is unusual and worth stating rather than glossing. It tops
the board because it wins on the two dimensions that are hardest to win simultaneously: a legally dated catalyst
and a Latent-to-Emergent hype position. Almost every other entry trades one for the other. The runner-up, SpaceX
float mechanics (82), has a harder date — Q2 results 4 Aug, first tranche 6 Aug — and lost on one dimension only:
it is the most written-about calendar entry in the US market. A perfect catalyst that everyone has circled is a
schedule, not an edge.

**Thesis.** For a class of US small-cap device and diagnostics companies, essentially all revenue runs through one
or two Medicare billing codes, so the price of that code — set by a regulator on a published rulemaking calendar —
is closer to the company's fundamentals than anything in its own investor deck.

**Catalyst, scored 19/20 not 20/20.** Dates are statutory: proposed rule 14 Jul 2026, comments close 14 Sep, final
rule in the autumn, rates effective 1 Jan 2027. The document is free, public and enormous — the profile of
information that gets under-consumed. The deduction is because a proposed rule is not a decision: CMS routinely
changes code-level valuations between proposal and final rule, the comment period exists precisely because
lobbying works, and the final rule's publication date is not fixed in advance.

**What must be true:** (1) code concentration can actually be verified from primary filings, not inferred;
(2) the proposed-to-final gap is not already priced by healthcare specialists; (3) the rate change is material to
the P&L rather than to the narrative — a 1.2% conversion-factor trim is noise.

**Strongest case against.** Reimbursement analysis is a recognised discipline with dedicated funds, consultants and
sell-side coverage; the claim that a retail researcher with a PDF systematically beats twenty-year CMS watchers is
implausible on its face, and the narrower defensible claim — that coverage density collapses below a certain size
— might simply be false. Worse, the Sanuwave precedent cuts both ways: that stock fell because rates *didn't*
change, meaning the market was positioned for a move a careful reader might well have predicted wouldn't happen —
and would then have been short a microcap into a policy non-event. Reimbursement outcomes reach price through a
positioning layer you cannot see. Third, companies do not tabulate revenue by CPT code; reconstructing it means
inference, and inference dressed as primary research is how a thesis becomes a story. Fourth, a business whose
economics live inside one regulator-set number has a single point of failure — the research edge and the risk are
the same fact viewed from two sides.

**Kill conditions (observable):** the 14 July proposed rule produced no measurable price dispersion across affected
names; the code-concentration list cannot be built from primary filings in a couple of hours; sell-side notes on
code-level changes appear within days of a proposed rule; the affected names move on the final rule's publication
rather than into it; the rulemaking calendar slips via shutdown, litigation or a statutory patch, converting the
dated catalyst into an undated one.

**Not picked, and why:** SpaceX float mechanics (82) — the closest call, arguably the better trade, disqualified on
crowding. The 10 November rare-earth cliff (77) — genuinely tempting, with sentiment cooling into a hard binary
date, but the outcome is a sovereign decision and no amount of reading gets you inside that room; the same
objection that ruled out the gold takeover in Run #1. Semiconductors (48) and quantum (46) — both cheaper stories
than they were on Monday, but a crowded trade that has started unwinding is not the same thing as an early one.

**Framing note.** A research subject, not a buy call, and deliberately not one. Recorded so the selection logic can
be judged against what actually happens.

### How Run #1's Idea of the Day has aged — Critical-minerals capital discrimination (entered 76)

**One day in: the thesis is intact but the entry note contained two errors, both of which weaken it.** First, the
catalyst window was logged as "Aug–Sep quarterly cashflow reports"; the June-quarter Appendix 5B lodgements are in
fact due **31 July**, so the event is two days away rather than a month. Second, and more damaging, the entry
claimed the edge came from computing cash ÷ burn to get runway "before the market fully prices it" — but item 8.3
of the Appendix 5B requires the company to *state its own estimated quarters of funding available*. The arithmetic
that was presented as under-consumed work is a disclosed field on a standardised form. The dispersion thesis may
still be right; the specific reason given for why it would be under-priced was wrong. Score reduced 76 → 72 for
that, and the entry now carries the correction on the live page rather than only here.

### Run notes

- **The crowding warning was tested within 24 hours, and this needs stating carefully.** Run #1's loudest line was
  that a watchlist concentrated in the hot half of the sentiment map is one position wearing twelve costumes. On
  28 July capital rotated out of high-valuation technology into industrials, financials and defensives;
  semiconductors and quantum fell together. That is the described correlation appearing on schedule. **One day is
  not evidence of a working process** and is not claimed as such. It is logged because omitting it would be
  selective, and a system that only records its hits is marketing.
- **Scoring discipline held.** The two highest-attention items fell hardest in score (semis 58→48, quantum 55→46)
  while the least-discussed new entry scored highest (83). That is the intended behaviour of the hype-position and
  sentiment weights. If a future run ever produces the top score on the most-discussed name, the scoring has
  drifted.
- **A narrative was registered without a watchlist entry.** Australian defence procurement reform meets the
  three-independent-source bar for registration but has no sourced small-cap expression, so it appears in the
  narrative register only. Manufacturing a ticker list to fill the row would have been the single most damaging
  thing available this run.
- **Tier migration recorded with a structural reason.** Uranium moved Tier 3 → Tier 2 because the expression of
  the theme migrated from microcap explorers to liquid developers with better disclosure and order books — not
  because it went up. The score still *fell*, because the dated catalyst was consumed and the next one is undated.
- **Coverage gap.** No HotCopper or r/ASX_Bets summary later than Week 28 was retrievable. ASX retail sentiment
  readings are carried forward from 28 July and are up to nineteen days stale. Logged on the live page too.
- **Macro overlay.** The FOMC decision lands 29 July with rates widely expected to hold at 3.50–3.75%, but the
  median forecast implies a possible hike before year-end on energy-led inflation. Diversifying across ASX
  explorers, US microcaps and alternative assets does not diversify across the rate path.
- **Weakest links in this run.** The reimbursement idea's central weakness is that its edge claim is unfalsifiable
  until someone actually tries to build the code-concentration list — it is scored 83 on the assumption that the
  data is retrievable, and that assumption is untested. The copper discovery entry (#8) rests on one company's
  drill results and is a single-name idea wearing a theme's clothing. Three entries (#9, #10, #13) were carried
  with no new information at all and exist on the page mainly as staleness-clock candidates.
- **No Tier 4 entries.** Second consecutive run. Logged as a fact, not an omission.

---

## 2026-07-30 — Run #3

Scope: ASX small/microcaps, US small/microcaps, alternative assets, cross-cutting policy. 20 source queries.
1 new opportunity, 5 materially changed, 1 retired, 6 carried with no new information and scored down for
staleness. 13 active, 10 narratives registered. One narrative upgraded from "registered but not expressible" to a
live watchlist entry. No new narratives registered.

| # | Opportunity | Market | Narrative | Sentiment | Stage | Tier | Score | Source |
|---|---|---|---|---|---|---|---|---|
| 1 | Medicare reimbursement calendar (was 83) — **CHANGED +2** | US | Materially strengthened and simultaneously relocated. Orthofix Medical, whose core revenue bills through HCPCS codes E0747/E0748/E0760, rose sharply after CMS issued revised guidance on 1 Jul withdrawing the May billing and fee-schedule changes for non-invasive bone growth stimulators and restoring prior reimbursement levels — reported moves ~10% immediately and ~16% on full repricing, ~28% across July against −23% YTD. Two of the entry's five kill conditions were answered in the affirmative: code concentration **is** verifiable from primary filings (the company named the codes in an 8-K), and reimbursement changes **do** move small caps hard. But the trigger was an unscheduled mid-cycle reversal, upstream of which sat an April FDA reclassification of the devices from Class III to Class II — not the annual rulemaking calendar the 20/20 catalyst score was built on | Neutral | Latent → Emergent | 2 | 85 | [CMS](https://www.cms.gov/newsroom/fact-sheets/calendar-year-cy-2027-medicare-physician-fee-schedule-proposed-rule), [Orthofix 8-K via StockTitan](https://www.stocktitan.net/sec-filings/OFIX/8-k-orthofix-medical-inc-reports-material-event-d04102d3e24a.html), [Investing.com](https://www.investing.com/news/stock-market-news/orthofix-medical-stock-surges-on-medicare-reimbursement-reversal-93CH-4776786), [Benzinga](https://www.benzinga.com/markets/small-cap/26/07/60593569/russell-2000-small-cap-stocks-july-biggest-gainers-2026) |
| 2 | SpaceX listed-float mechanics (NASDAQ:SPCX) — **CHANGED, score held** | US | The schedule firmed rather than softened. Maiden quarterly report confirmed for 4 Aug; first window opens on the second full trading day after, ~6 Aug, freeing up to 20% of ~911.5m restricted shares; ~7% tranches every two to four weeks Aug–Oct; ~28% triggered by the Q3 report; remaining 180-day shares release 8 Dec 2026. Conditional 10% early release if the stock closed >30% above the $135 IPO price in five of the ten sessions before the report. Musk's ~6.4bn shares locked to 12 Jun 2027 | Excited | Acceleration | 1 | 82 | [Investing.com](https://www.investing.com/news/stock-market-news/spacex-ipo-lockup-expiry-123b-in-shares-set-to-unlock-in-early-august-2026-93CH-4796311), [Yahoo Finance](https://finance.yahoo.com/markets/stocks/articles/spacex-sets-date-maiden-earnings-204821563.html) |
| 3 | Rare earths and the 10 November cliff — carried, direction confirmed | ASX | No change to the 10 Nov 2026 expiry of China's suspension. Supporting detail added: MOFCOM Announcement No. 26, effective 1 Jul 2026, established a public reporting and whistleblower mechanism for strategic-mineral export-control violations, including mandatory reporting duties on freight forwarders and banks. Enforcement machinery is being built while the headline restriction sits suspended — the opposite of a softening | Excited (cooling) | Acceleration ↓ | 2 | 77 | [China Briefing](https://www.china-briefing.com/news/chinas-rare-earth-export-controls-impacts-on-businesses/), [Morgan Lewis](https://www.morganlewis.com/pubs/2026/07/recent-china-export-control-actions-signal-active-enforcement-for-rare-earths-and-strategic-minerals), [Geopolitechs](https://www.geopolitechs.org/p/beijing-tightens-critical-mineral) |
| 4 | Critical-minerals capital discrimination (was 72) — **CHANGED +2** | ASX | The dispersion acquired a named aggregate measure. BDO's explorer cash tracking recorded a record $13.04bn of aggregate explorer cash in the March 2026 quarter, average cash per explorer $17.39m, and the top 50 explorers by market capitalisation holding 53% of total cash while accounting for only 15% of financing inflows. Yesterday's correction still stands — item 8.3 runway is disclosed, not derived — so the score rose on evidence rather than on a repaired premise. June-quarter Appendix 5B lodgements due 31 Jul | Cautious | Emergent | 2 | 74 | [ASX Appendix 5B](https://www.asx.com.au/content/dam/asx/rules-guidance-notes-waivers/asx-listing-rules/appendices/Appendix_05B.pdf), [BDO Explorer Quarterly Cash Update](https://www.bdo.com.au/en-au/insights/natural-resources-energy/explorer-quarterly-cash-update-march-2026-quarter) |
| 5 | **Australian sovereign defence capability** (DroneShield, Electro Optic Systems, Austal, Bisalloy, Codan) — **NEW** | ASX | The narrative registered yesterday as Latent with no sourced small-cap expression acquired one within 24 hours. 8 Jul: third Mission Syracuse contract announced through the Advanced Strategic Capabilities Accelerator — $5.7m to EOS for the R400 SLINGER counter-UAS capability, taking mission investment to $37.4m after earlier awards to AIM Defence and SYPAQ. 28 Jul: the listed pure-play reported HY26 revenue ~$125.8m (+74% YoY), ~$23.2m of new European vehicle-mounted orders placed through a Benelux reseller (~$21m counting to 2026 committed revenue, balance later as subscription), committed 2026 revenue ~$206m with 13% recurring, FY guidance $250–270m — **and fell ~10%**, on HY26 gross margin near 60% vs ~65% pcp and guidance ~17–23% below a published consensus near $323m. Short interest ~12.8%, up ~7m shares since 1 Jul | Excited, turning | Acceleration | 2 | 73 | [Defence Ministers](https://www.minister.defence.gov.au/media-releases/2026-07-08/third-mission-syracuse-contract-boost-counter-drone-capability), [ASCA](https://www.asca.gov.au/activities/missions/mission-syracuse), [Proactive](https://www.proactiveinvestors.com/companies/news/1096109/droneshield-secures-a-23-2-million-european-defence-contracts-as-first-half-revenue-surges-74-1096109.html), [Rask Media](https://www.raskmedia.com.au/2026/07/28/droneshield-asxdro-share-price-falls-10-on-hy26-trading-update/), [Capital Brief](https://www.capitalbrief.com/briefing/droneshield-shares-tank-following-first-half-trading-update-new-contract-package-84154d52-d952-4ec7-8438-7c011155ff52/) |
| 6 | Prediction markets as an asset class (was 71) — **CHANGED −2** | Alt | Scored down on regulatory friction, not on volume. Volume records continued — over $27bn of World Cup trading across ~33,000 distinct event contracts. But on 24 Jul the CFTC's Division of Market Oversight issued an advisory reminding designated contract markets of the procedures required to self-certify new products, in substance telling exchanges to stop self-certifying broad series of event contracts from blanket templates. That raises the cost of the mechanism generating the growth. SEC still holding up to 24 event-contract ETF filings; Polymarket preparing formal US re-entry via its QCEX acquisition | Excited | Acceleration → Saturation gate | 2 | 69 | [Crypto Times](https://www.cryptotimes.io/2026/07/27/cftc-tells-kalshi-polymarket-to-stop-blanket-filings/), [CoinDesk](https://www.coindesk.com/policy/2026/07/27/kalshi-polymarket-win-pause-against-minnesota-s-prediction-market-ban), [RotoWire](https://www.rotowire.com/prediction-markets/legal-timeline) |
| 7 | Uranium & nuclear fuel cycle (was 66) — **CHANGED −1** | ASX | No new information. Scored down one because the next catalyst — commercial offtakes between Australian miners and Indian utilities following the 9 Jul framework — remains undated, and an undated next step degrades a catalyst score over time rather than holding it | Excited | Acceleration → flat | 2 | 65 | [Al Jazeera](https://www.aljazeera.com/news/2026/7/9/australia-india-strike-deal-on-uranium-exports-during-pm-modis-visit), [Proactive](https://www.proactiveinvestors.com.au/companies/news/1095234/australia-india-uranium-deal-opens-major-new-market-for-local-producers-1095234.html) |
| 8 | ASX antimony & critical-mineral explorers — carried, score held | ASX | A 22 Jul Proactive Small Cap Watch confirms Krakatoa is running drilling, geological modelling, site investigations and metallurgical preparation concurrently at Zopkhito toward a maiden JORC-compliant resource estimate. Progress, not results. The assays remain the catalyst | Cautious | Emergent | 3 | 65 | [Proactive Small Cap Watch, 22 Jul](https://www.proactiveinvestors.com/companies/news/1095890/small-cap-watch-explorers-advance-drilling-surveys-and-resource-work-1095890.html) |
| 9 | ASX copper discovery cycle (Solstice Minerals, Nanadie Well WA) — carried, no new information | ASX | Unchanged from Run #2. Eleven diamond tails still pending hole-by-hole through H2 2026 | Excited | Emergent | 3 | 61 | [Livewire](https://www.livewiremarkets.com/wires/solstice-shares-head-for-the-sun-as-bumper-copper-gold-hits-break-discovery-drought), [Small Caps](https://smallcaps.com.au/article/solstice-minerals-extends-nanadie-copper-gold-system-at-depth) |
| 10 | ASX IPO-flip trade (FDC Consolidated Holdings, was 57) — **CHANGED −2** | ASX | Third consecutive run with no new information. Scored down for staleness and now the leading retirement candidate. Its escrow and lock-up dates have never been sourced from a primary document — only from forum coverage, which is Tier C and cannot support a factual claim | Neutral | Acceleration | 2 | 55 | [HotCopper Wk28](https://hotcopper.com.au/news/market-summary/155159/hotcopper-highlights-week-28-tech-stock-relief-asxs-largest-ipo-of-2026-more/) |
| 11 | ASX lithium recovery trade (was 54) — **CHANGED −1** | ASX | Third consecutive run with no new information. Retained because the June-quarter reporting round from 31 Jul is the natural refresh point | Neutral | Latent → Emergent | 2 | 53 | [Discovery Alert](https://discoveryalert.com.au/hotcopper-highlights-week-28-asx-stocks-market-sentiment-2026/) |
| 12 | Semiconductor & AI-infrastructure complex (was 48) — **CHANGED −1** | US | No new information. Scored down one: a narrative in Decay with no fresh catalyst decays in score as well as in attention | Euphoric, turning | Saturation → Decay | 1 | 47 | [CNBC](https://www.cnbc.com/2026/07/28/china-chipmaking-duv-tool-asml-explained.html), [Tom's Hardware](https://www.tomshardware.com/tech-industry/semiconductors/china-begins-mass-production-of-domestic-immersion-duv-lithography-machines) |
| 13 | Quantum computing pure-plays (was 46) — **CHANGED −1** | US | No new information. Same reasoning as above | Euphoric, turning | Saturation | 2 | 45 | [Yahoo Finance](https://finance.yahoo.com/markets/stocks/articles/ionq-rigetti-d-wave-quantum-183030435.html), [Motley Fool](https://www.fool.com/investing/stock-market/market-sectors/information-technology/ai-stocks/quantum-computing-stocks/) |

### Retired this run

| Entry | Entry score | Rule triggered | Detail |
|---|---:|---|---|
| BrainChip / neuromorphic commercialisation (ASX:BRN) | 38 | **Narrative in Decay + three runs with no new information** | Retiring it on the Decay rule is partly an admission, and that should be said plainly: the entry was logged at "Decay ↔ Recycle" on day one, so the retirement rule was arguably satisfied at entry. It never had a dated catalyst; its only qualification for the page was attention. Nothing new has been sourced since 28 July. Retained permanently here as the reference example of "perpetual near-term milestones" — a technology narrative that recycles indefinitely because it is never falsified, only postponed. [Discovery Alert](https://discoveryalert.com.au/hotcopper-highlights-week-28-asx-stocks-market-sentiment-2026/) |

### Narrative register state — 30 July 2026

| Narrative | Stage | Direction (vs Run #2) | First logged | Kill condition status |
|---|---|---|---|---|
| Non-China critical minerals | Acceleration | ↓ Cooling into a dated cliff, enforcement tightening underneath | 28 Jul 2026 | Mixed. Magnet exports to the US still elevated, but MOFCOM Announcement No. 26 is building enforcement machinery from 1 Jul |
| AI infrastructure buildout | Saturation → Decay | ↓ Cracking (unchanged, no new information) | 28 Jul 2026 | **Firing.** No new evidence today either way |
| Quantum as "the next AI" | Saturation | ↓ Unwinding (unchanged, no new information) | 28 Jul 2026 | **Partly firing.** No new evidence today |
| Nuclear / uranium revival | Acceleration | → Flat (was ↑ Building) | 28 Jul 2026 | Not firing, but the next catalyst is undated, which is its own kind of decay |
| Prediction markets go mainstream | Acceleration → Saturation gate | ↑ Volume fast, ↓ regulatory path narrowing | 28 Jul 2026 | **Partly firing.** The 24 Jul CFTC advisory constrains self-certification, which is the growth mechanism |
| Space commercialisation | Acceleration | → Steady, expressed as float mechanics; 4 Aug date confirmed | 28 Jul 2026 | Not firing. The August unlock absorption is the test |
| Collectibles as an asset class | Decay (modern) / Saturation (vintage) | ↓ Bifurcation persisting | 28 Jul 2026 | **Firing.** Retired from the watchlist 29 Jul; narrative still tracked |
| Lithium price recovery | Latent → Emergent | → Waiting (third run, no new information) | 28 Jul 2026 | Not assessed. Refresh point is the 31 Jul reporting round |
| Reimbursement as a catalyst class | Latent → Emergent | ↑ Advancing, but **relocating** | 29 Jul 2026 | Two kill conditions answered in the affirmative — code concentration verifiable, dispersion real. But the demonstrated sub-class is *unscheduled mid-cycle billing changes*, which have no publication date. The narrative got stronger and the dated version of it got weaker |
| Australian sovereign defence capability | Acceleration | ↑ **Now expressible** (was Latent, not expressible) | 29 Jul 2026 | **Partly firing.** The first pure-play to report against the theme fell on good revenue news, on margin and guidance. Registered yesterday with no expression; today it has one, and the expression is already at the saturation gate |

### Idea of the Day — #5, The margin question inside Australia's defence-spending narrative (score 73)

**Selection logic.** This is the **fifth-highest scorer** and the gap needs justifying. Today's top scorer (85) is
yesterday's pick, which rose on genuinely strong evidence and was still not re-picked — because the new evidence
confirmed the *materiality* and undercut the *datedness*. The largest reimbursement-driven small-cap move of the
year came from an unscheduled 1 July reversal, not from the annual rulemaking calendar the idea was built around.
SpaceX float mechanics (82) firmed further and lost for the same reason as yesterday: universally circled.
The 10 November rare-earth cliff (77) still resolves to a sovereign decision. Critical-minerals capital
discrimination (74) was the closest call, with a catalyst tomorrow, but its edge premise remains the one corrected
on 29 July. Today's pick wins on the dimension scoring cannot capture: a specific falsifiable question that public
disclosure can answer and almost nobody is asking.

**Thesis.** Australia's defence narrative has moved from budget announcements to delivery, so the tradeable
question is no longer whether the orders arrive — they are arriving — but **what margin those orders carry**, and
that is decomposable from public disclosure before the August half-year results.

**Catalyst, scored 15/20.** The audited HY26 result lands in late August on a reporting deadline and will contain
the segment and channel detail the 28 July trading update omitted. The question is pre-specifiable: is the gross
margin decline a one-off, a hardware-versus-subscription mix shift, or a reseller-channel effect? The 28 July
release handed over a clue by naming the counterparty — the European orders came through a Benelux reseller, not a
direct government sale. Marked down five points because a half-year result is a date, not a resolution: companies
explain margin compression in self-serving language, and short interest near 12.8% means the reaction function is
dominated by positioning rather than by the numbers.

**What must be true:** (1) the margin decline is decomposable from public disclosure — channel, product and
recurring-versus-hardware mix broken out finely enough to separate one-off from structural; (2) margin is genuinely
the swing factor rather than demand, since guidance below consensus is a timing statement as much as a margin one;
(3) the pattern is sector-wide rather than one company's cost problem wearing a theme's clothing.

**Strongest case against.** The fatal objection is that this is not an under-followed situation: short interest
around 12.8%, up roughly 7 million shares in under a month, means sophisticated capital was already positioned on
the bear side of exactly this question and got paid on 28 July. This system's entire scoring premise is that
crowded ideas offer less; a stock with a record short base, daily retail commentary and broker notes inside a week
is crowded. The honest read is that the *narrative* is early and the *expression* is not, and picking it anyway is
a judgement call that may simply be wrong. Second, margin decomposition is what analysts do and published broker
commentary on sector competition appeared within a day. Third — and most likely to be right — a 60% gross margin on
74% revenue growth with a shift into vehicle-mounted hardware sold through international resellers is the
*mechanically expected* outcome, not a puzzle; if so there is nothing to research, just a market repricing a
valuation that had assumed growth and margin simultaneously. Fourth, defence procurement narratives absorb bad news
unusually well, because programs are announced years ahead in round numbers with political incentives to restate
them — the 2 July reporting on Australia seeking to rein in cost blowouts is the reminder that reform can mean
discipline rather than new money. Fifth, one name carries most of the liquidity and attention, which makes the
sector-wide test the one most likely to fail. **Sixth, and possibly fatal: the narrative and the cash flow point at
different continents.** Mission Syracuse has contracted $37.4m in total against full-year guidance of $250–270m,
and the 28 July orders were European, routed through a Benelux reseller — so the Australian sovereign-capability
story may be decoration on a European order book, which would make the pick wrong at the level of framing rather
than analysis. Seventh, an accounting conclusion reprices slowly if at all in a stock whose price is set by policy
headlines and short-covering: being right about the mechanism and being paid are different events, which is now the
third idea on this page to carry that same objection.

**Kill conditions (observable):** the half-year result attributes the margin decline to a supportable one-off;
the reports do not break out channel or product mix finely enough to separate reseller from direct revenue;
guidance is cut again at the result, making this a demand story; short interest falls sharply into the result,
removing the asymmetry; the other listed expressions show no comparable margin or channel dynamic when they report;
Mission Syracuse or the wider counter-drone program is paused, reprofiled or moved to a slower acquisition pathway;
the half-year geographic split shows Australian revenue is immaterial, making the narrative label wrong; a
well-argued margin conclusion produces no repricing at all.

**Not picked, and why:** the Medicare reimbursement calendar (85) — top scorer, yesterday's pick, and the reason for
skipping it is recorded above and on the live page in full, because an idea that gets stronger and weaker on the
same day is the most instructive thing this run produced. SpaceX float mechanics (82) — the schedule firmed;
the crowding did not improve. Critical-minerals capital discrimination (74) — genuinely close, catalyst tomorrow,
still carrying the 29 July correction.

**Framing note.** A research subject, not a buy call, and deliberately not one. Named companies are examples of
where a narrative is being expressed. Recorded so the selection logic can be judged against what happens.

### How Run #2's Idea of the Day has aged — The Medicare reimbursement calendar (entered 83)

**One day in: the strongest possible confirmation of the mechanism, delivered by an event that invalidates the
reason the idea scored 83.** Orthofix Medical — whose core revenue bills through HCPCS codes E0747, E0748 and
E0760 — rose roughly 10% and then about 16% after CMS issued revised guidance on 1 July withdrawing the billing and
fee-schedule changes it had made in May for non-invasive bone growth stimulators, and about 28% across July while
remaining down about 23% for the year. That resolves two of the five kill conditions in favour of the thesis: code
concentration is verifiable from primary filings, because the company named the exact codes in an 8-K, and
reimbursement changes do produce large single-name moves in small caps. **But the catalyst was not the annual fee
schedule.** It was an unscheduled mid-cycle reversal, itself downstream of an FDA reclassification of those devices
from Class III to Class II in April. The entry scored 19/20 on catalyst strength specifically because the CMS
rulemaking calendar is statutory and dated; the version of the idea that actually paid this month had no date at
all. The score rose to 85 on evidence. The premise behind the score is now weaker than it was, and that is why the
entry was not re-picked. Logged in full because a system that records confirmations and quietly omits the part that
complicates them is marketing.

### Run notes

- **Deliberate demonstration of the selection rule.** Yesterday the top scorer was the pick and the page said so
  while noting it would usually not be. Today the pick is fifth by score, and the reasoning for skipping four
  higher-scoring items is set out in full. If the pick and the top score coincide more than occasionally in future
  runs, the selection has collapsed into ranking.
- **Crowding observation.** Still eight of thirteen entries in Excited or Euphoric, and three now carry "turning."
  That is a worse state than euphoric-and-rising: the exit and the enthusiasm are in the same place. Worth being
  blunt that the new entry added today made this worse, not better — it entered the sentiment map hot.
- **A score rose while its premise fell.** The reimbursement entry went 83 → 85 on evidence and simultaneously lost
  the dated-catalyst logic that justified the score. Both facts are on the live page. This is the most useful thing
  in the run and the least comfortable.
- **Retirement was overdue, not timely.** BrainChip was logged at Decay on day one and carried for three runs. The
  retirement rules were satisfied at entry. Logged as a process failure rather than a routine cull.
- **Tier D noted.** Searches on Australian defence stocks surfaced two subscription stock-recommendation sites
  publishing "best defence stocks to buy now" style lists. Excluded as Tier D. Their presence around a theme that
  has just reached Acceleration is itself a negative signal and is recorded as one.
- **A sandbox scenario was added.** Scenario F, the growth beat that trades like a miss, generalised from the
  28 July pattern. It is distinct from the existing sell-the-news scenario: there the anticipated event disappointed
  by arriving, here the event was genuinely good and the reaction was set by margin, mix and a published consensus.
- **Coverage gap, third consecutive run.** No HotCopper or r/ASX_Bets summary later than Week 28 was retrievable
  again. ASX retail sentiment is carried forward from 28 July and is now up to twenty days stale, while the
  sentiment dimension carries 15 of 100 points. This is now the largest known structural weakness in the page and
  is stated as such on the live page, not only here.
- **Macro overlay — hawkish hold.** The FOMC held at 3.50–3.75% on 29 July for a fifth consecutive meeting, but the
  vote was 9–3 with three regional Reserve Bank presidents dissenting in favour of a hike, and year-end projections
  spanning roughly 3.6% to 4.1%. Every narrative here is funded by the same risk appetite.
- **Weakest links in this run.** Today's pick is the weakest link in it: a heavily shorted, heavily discussed name
  chosen on the argument that the narrative is earlier than the expression, which is a distinction that may not
  survive contact with the tape. Six entries were carried with no new information at all (#3, #8, #9, #10, #11,
  and #12/#13 jointly), which means nearly half the page is running on momentum from earlier runs. Three entries
  are now on a staleness clock.
- **No Tier 4 entries.** Third consecutive run. Logged as a fact, not an omission.

---

*Next scheduled run: 31 July 2026, 6:30 AM AWST.*